SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-10-234617
Filing Date
2010-10-22
Accepted
2010-10-22 16:08:23
Documents
11
Period of Report
2010-10-19
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 3.03: Material Modifications to Rights of Security Holders
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d8k.htm 8-K 30007
2 LETTER AGREEMENT dex11.htm EX-1.1 91128
3 ARTICLES OF AMENDMENT TO AMENDED AND RESTATED ARTICLES OF INCORPORATION dex31.htm EX-3.1 76874
4 FORM OF SERIES 7 PREFERRED STOCK CERTIFICATE dex41.htm EX-4.1 9469
5 FORM OF COMMON STOCK PURCHASE WARRANT dex42.htm EX-4.2 67975
6 OPINION OF KARR TUTTLE CAMPBELL dex51.htm EX-5.1 13525
7 FORM OF SECURITIES PURCHASE AGREEMENT dex101.htm EX-10.1 146055
8 PRESS RELEASE dex991.htm EX-99.1 9378
9 GRAPHIC g110849g70w78.jpg GRAPHIC 3134
10 GRAPHIC g110849g80k59.jpg GRAPHIC 21297
11 GRAPHIC g110849g83y63.jpg GRAPHIC 4915
  Complete submission text file 0001193125-10-234617.txt   487033
Mailing Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119
Business Address 501 ELLIOTT AVE W STE 400 SEATTLE WA 98119 2062827100
CELL THERAPEUTICS INC (Filer) CIK: 0000891293 (see all company filings)

IRS No.: 911533912 | State of Incorp.: WA | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-12465 | Film No.: 101137453
SIC: 2834 Pharmaceutical Preparations